Essex Woodlands Management, Inc. Eye Point Pharmaceuticals, Inc. Transaction History
Essex Woodlands Management, Inc.
- $349 Million
- Q3 2024
A detailed history of Essex Woodlands Management, Inc. transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Essex Woodlands Management, Inc. holds 1,551,521 shares of EYPT stock, worth $10.3 Million. This represents 3.56% of its overall portfolio holdings.
Number of Shares
1,551,521
Previous 1,551,521
-0.0%
Holding current value
$10.3 Million
Previous $13.5 Million
8.16%
% of portfolio
3.56%
Previous 4.41%
Shares
4 transactions
Others Institutions Holding EYPT
# of Institutions
154Shares Held
58.3MCall Options Held
177KPut Options Held
263K-
Cormorant Asset Management, LP Boston, MA8.33MShares$55.1 Million4.66% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.18MShares$34.3 Million1.63% of portfolio
-
Franklin Resources Inc San Mateo, CA4.01MShares$26.6 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.79MShares$25.1 Million0.06% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$24.9 Million0.0% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $226M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...